The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection
Since their discovery, toxin-antitoxin (TA) systems have captivated the attention of many scientists. Recent studies have demonstrated that TA systems play a key role in phage inhibition. The aim of the present study was to investigate the role of the PemIK (PemK/PemI) type II TA system in phage inh...
| Autores: | , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Instituto de Salud Carlos III (ISCIII) |
| Repositorio: | Repisalud |
| Idioma: | inglés |
| OAI Identifier: | oai:repisalud.isciii.es:20.500.12105/14469 |
| Acceso en línea: | http://hdl.handle.net/20.500.12105/14469 |
| Access Level: | acceso abierto |
| id |
ES_a59e7e3f9f1e88167e8a0dda3caa3ada |
|---|---|
| oai_identifier_str |
oai:repisalud.isciii.es:20.500.12105/14469 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infectionBleriot, InesBlasco, LuciaPacios, OlgaFernández-García, LauraAmbroa, AntónLópez, MaríaOrtiz-Cartagena, ConchaCuenca, Felipe FernándezOteo-Iglesias, JesusPascual, ÁlvaroMartínez-Martínez, LuisDomingo-Calap, PilarWood, Thomas KTomás, MaríaSince their discovery, toxin-antitoxin (TA) systems have captivated the attention of many scientists. Recent studies have demonstrated that TA systems play a key role in phage inhibition. The aim of the present study was to investigate the role of the PemIK (PemK/PemI) type II TA system in phage inhibition by its intrinsic expression in clinical strains of Klebsiella pneumoniae carrying the lncL plasmid, which harbours the carbapenemase OXA-48 and the PemK/PemI TA system. Furthermore, induced expression of the system in an IPTG-inducible plasmid in a reference strain of K. pneumoniae ATCC10031 was also studied. The results showed that induced expression of the whole TA system did not inhibit phage infection, whereas overexpression of the pemK toxin prevented early infection. To investigate the molecular mechanism involved in the PemK toxin-mediated inhibition of phage infection, assays measuring metabolic activity and viability were performed, revealing that overexpression of the PemK toxin led to dormancy of the bacteria. Thus, we demonstrate that the PemK/PemI TA system plays a role in phage infection and that the action of the free toxin induces a dormant state in the cells, resulting in inhibition of phage infections.Nature Publishing GroupInstituto de Salud Carlos IIIPlan Nacional de I+D+i (España)Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)RETICS-Investigación en Patología Infecciosa (REIPI-ISCIII) (España)Sociedad Española de Enfermedades Infecciosas y Microbiología ClínicaXunta de Galicia (España)20222022-05-2420222022-03-1620222022-03-16research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/20.500.12105/14469reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Atribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/144692026-06-12T12:43:37Z |
| dc.title.none.fl_str_mv |
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection |
| title |
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection |
| spellingShingle |
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection Bleriot, Ines |
| title_short |
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection |
| title_full |
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection |
| title_fullStr |
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection |
| title_full_unstemmed |
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection |
| title_sort |
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection |
| dc.creator.none.fl_str_mv |
Bleriot, Ines Blasco, Lucia Pacios, Olga Fernández-García, Laura Ambroa, Antón López, María Ortiz-Cartagena, Concha Cuenca, Felipe Fernández Oteo-Iglesias, Jesus Pascual, Álvaro Martínez-Martínez, Luis Domingo-Calap, Pilar Wood, Thomas K Tomás, María |
| author |
Bleriot, Ines |
| author_facet |
Bleriot, Ines Blasco, Lucia Pacios, Olga Fernández-García, Laura Ambroa, Antón López, María Ortiz-Cartagena, Concha Cuenca, Felipe Fernández Oteo-Iglesias, Jesus Pascual, Álvaro Martínez-Martínez, Luis Domingo-Calap, Pilar Wood, Thomas K Tomás, María |
| author_role |
author |
| author2 |
Blasco, Lucia Pacios, Olga Fernández-García, Laura Ambroa, Antón López, María Ortiz-Cartagena, Concha Cuenca, Felipe Fernández Oteo-Iglesias, Jesus Pascual, Álvaro Martínez-Martínez, Luis Domingo-Calap, Pilar Wood, Thomas K Tomás, María |
| author2_role |
author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Instituto de Salud Carlos III Plan Nacional de I+D+i (España) Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) RETICS-Investigación en Patología Infecciosa (REIPI-ISCIII) (España) Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica Xunta de Galicia (España) |
| description |
Since their discovery, toxin-antitoxin (TA) systems have captivated the attention of many scientists. Recent studies have demonstrated that TA systems play a key role in phage inhibition. The aim of the present study was to investigate the role of the PemIK (PemK/PemI) type II TA system in phage inhibition by its intrinsic expression in clinical strains of Klebsiella pneumoniae carrying the lncL plasmid, which harbours the carbapenemase OXA-48 and the PemK/PemI TA system. Furthermore, induced expression of the system in an IPTG-inducible plasmid in a reference strain of K. pneumoniae ATCC10031 was also studied. The results showed that induced expression of the whole TA system did not inhibit phage infection, whereas overexpression of the pemK toxin prevented early infection. To investigate the molecular mechanism involved in the PemK toxin-mediated inhibition of phage infection, assays measuring metabolic activity and viability were performed, revealing that overexpression of the PemK toxin led to dormancy of the bacteria. Thus, we demonstrate that the PemK/PemI TA system plays a role in phage infection and that the action of the free toxin induces a dormant state in the cells, resulting in inhibition of phage infections. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 2022-05-24 2022 2022-03-16 2022 2022-03-16 |
| dc.type.none.fl_str_mv |
research article http://purl.org/coar/resource_type/c_2df8fbb1 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/20.500.12105/14469 |
| url |
http://hdl.handle.net/20.500.12105/14469 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 4.0 Internacional http://creativecommons.org/licenses/by/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 Atribución 4.0 Internacional http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Nature Publishing Group |
| publisher.none.fl_str_mv |
Nature Publishing Group |
| dc.source.none.fl_str_mv |
reponame:Repisalud instname:Instituto de Salud Carlos III (ISCIII) |
| instname_str |
Instituto de Salud Carlos III (ISCIII) |
| reponame_str |
Repisalud |
| collection |
Repisalud |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869415630321483776 |
| score |
15,811543 |